"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted

MAP Verified Summary — reported by Ars Technica

Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.

This story’s context record documents 7 observable dimensions — Origin, Attribution, Specificity, Timing, Framing, Context Change, and Information Relationships — as part of Media Alert Press’s context-documentation ledger. MAP does not score or rate this content. Read the full original story at Ars Technica →

View MAP Context →